Lifestyle interventions and physical activity

The results of a small randomized trial suggest exercise is more helpful than diet for combating early cardiac dysfunction associated with type 2 diabetes, although both may be beneficial.

People who are trying to maintain weight loss with the help of electronic health records-based tracking tools do significantly better if they are given access to an online coach, shows a randomized trial.

A pilot study published in JAMA shows that although heat stress is a potential issue for men with type 2 diabetes who wish to exercise, they may be able to acclimatize through repeated brief exposures.

Short-term structured strength and balance training does not improve quality of life in patients with type 2 diabetes-related peripheral neuropathy, but may increase functional status and balance confidence, research shows.

The effectiveness of interventions to increase objectively measured physical activity in people at high risk for developing type 2 diabetes declines in line with symptoms of depression within the normal range, say researchers.

A high volume of moderate-to-vigorous intensity exercise during the first trimester of pregnancy may reduce the risk for hyperglycemia and gestational diabetes later on, research shows.

Findings from the GRAVITAS trial indicate that use of the GLP-1 receptor agonist liraglutide alongside a diet and physical activity intervention may improve glycemic control among people with persistent or recurrent type 2 diabetes after bariatric surgery.

Even with newer devices, continuous glucose monitoring underestimates the fall in glucose levels during exercise, with the drop lagging significantly behind that measured by self-monitoring of blood glucose, research shows.

A 1-year exercise intervention combining high-intensity interval training with resistance training may improve measures of cardiovascular risk among people with type 2 diabetes, suggests a secondary analysis of the D2FIT trial.

A behavioral intervention has lasting effects on physical activity levels, fitness, and vascular risk in people with type 2 diabetes, show the 3-year results of the randomized Italian Diabetes and Exercise Study 2.

The PREVIEW project investigators have reported broadly positive results, but tempered by issues such as a high dropout rate.

Preliminary findings from a randomized crossover trial suggest that patients with type 1 diabetes who reduce their dose of insulin degludec before regular exercise may experience an improvement in the time spent in normoglycemia.

Patients with diabetes have an increased risk for arthritis, osteoporosis, and musculoskeletal pain, study findings indicate.

Sedentary time, higher intensity physical activity (HPA), and cardiorespiratory fitness all independently affect the risk for type 2 diabetes and the metabolic syndrome, data from The Maastricht Study show.

Physical inactivity is a “significant but underappreciated contributor” to the risk of developing diabetes in people who are already at high risk and should be routinely measured in clinical trials, say the NAVIGATOR investigators.

Modestly increasing glucagon levels when commencing physical activity could be an effective strategy for preventing exercise-induced hypoglycemia among patients with type 1 diabetes, results of a randomized crossover trial suggest.

Using a dual-hormone closed-loop insulin delivery system that detects when the wearer is doing exercise results in a low rate of exercise-induced hypoglycemia, show findings from a small randomized study.

Findings of a randomized trial suggest that challenging people’s habits can lead to sustained weight loss, even if the habits targeted have nothing to do with healthy eating.

Analysis of data from the Look AHEAD trial suggests that a long-term intensive lifestyle intervention could delay the onset of physical disability among overweight and obese patients with type 2 diabetes.

Results of an observational study suggest that doing exercise around the time of type 1 diabetes diagnosis could extend the “honeymoon” period of low insulin requirement.